Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Abstract Background The creation of breast cancer practice guidelines requires proper management of financial relationships with drug companies, as they can introduce conflicts of interest (COIs) among guideline authors. However, little is known about the specific landscape and fraction of financial...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anju Murayama, Kenichi Higuchi, Keerthana R. Byreddy, Kugo Hinari, Yuki Senoo
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2024-06-01
Col·lecció:	Clinical and Translational Discovery
Matèries:	clinical practice guideline conflicts of interest ethics evidence‐based medicine health policy pharmaceutical companies
Accés en línia:	https://doi.org/10.1002/ctd2.304
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!